Cargando…

The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice

BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between B...

Descripción completa

Detalles Bibliográficos
Autores principales: Piek, Marceline W., de Boer, Jan Paul, van Duijnhoven, Frederieke, van der Wal, Jacqueline E., Vriens, Menno, van Leeuwaarde, Rachel S., van der Ploeg, Iris M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511724/
https://www.ncbi.nlm.nih.gov/pubmed/36163009
http://dx.doi.org/10.1186/s12885-022-10069-6
_version_ 1784797701104205824
author Piek, Marceline W.
de Boer, Jan Paul
van Duijnhoven, Frederieke
van der Wal, Jacqueline E.
Vriens, Menno
van Leeuwaarde, Rachel S.
van der Ploeg, Iris M. C.
author_facet Piek, Marceline W.
de Boer, Jan Paul
van Duijnhoven, Frederieke
van der Wal, Jacqueline E.
Vriens, Menno
van Leeuwaarde, Rachel S.
van der Ploeg, Iris M. C.
author_sort Piek, Marceline W.
collection PubMed
description BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands. METHODS: This is a retrospective cohort study during the period of 1989–2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS). RESULTS: The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40–2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09–1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone. CONCLUSION AND RELEVANCE: The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland.
format Online
Article
Text
id pubmed-9511724
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95117242022-09-27 The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice Piek, Marceline W. de Boer, Jan Paul van Duijnhoven, Frederieke van der Wal, Jacqueline E. Vriens, Menno van Leeuwaarde, Rachel S. van der Ploeg, Iris M. C. BMC Cancer Research BACKGROUND: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands. METHODS: This is a retrospective cohort study during the period of 1989–2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS). RESULTS: The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40–2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09–1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone. CONCLUSION AND RELEVANCE: The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland. BioMed Central 2022-09-26 /pmc/articles/PMC9511724/ /pubmed/36163009 http://dx.doi.org/10.1186/s12885-022-10069-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Piek, Marceline W.
de Boer, Jan Paul
van Duijnhoven, Frederieke
van der Wal, Jacqueline E.
Vriens, Menno
van Leeuwaarde, Rachel S.
van der Ploeg, Iris M. C.
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title_full The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title_fullStr The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title_full_unstemmed The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title_short The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
title_sort co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511724/
https://www.ncbi.nlm.nih.gov/pubmed/36163009
http://dx.doi.org/10.1186/s12885-022-10069-6
work_keys_str_mv AT piekmarcelinew thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT deboerjanpaul thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanduijnhovenfrederieke thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanderwaljacquelinee thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vriensmenno thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanleeuwaarderachels thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanderploegirismc thecooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT piekmarcelinew cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT deboerjanpaul cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanduijnhovenfrederieke cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanderwaljacquelinee cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vriensmenno cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanleeuwaarderachels cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice
AT vanderploegirismc cooccurrenceofbothbreastanddifferentiatedthyroidcancerincidenceassociationandclinicalimplicationsfordailypractice